Clinical Trials · NCT02437825

Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery

Name: Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 2Octreotide

Phase: Phase 2
Recruitment status: Unknown
Sponsor: Hadassah Medical Organization
Enrollment: 40
Start date: Oct 2015
Locations: 1 site, Israel
Primary endpoint: elimination of post-radiation salivary fistulae

View Octreotide compound reference